TEVA vs. IHE
TEVA (Teva Pharmaceutical Industries Limited) is a stock, while IHE (iShares U.S. Pharmaceuticals ETF) is Health & Biotech Equities fund tracking the Dow Jones U.S. Select Pharmaceuticals Index. Over the past 10 years, TEVA returned -4.49%/yr vs 8.49%/yr for IHE. At a 0.45 correlation, their price movements are largely independent.
Performance
TEVA vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEVA achieves a 0.87% return, which is significantly lower than IHE's 8.99% return. Over the past 10 years, TEVA has underperformed IHE with an annualized return of -4.49%, while IHE has yielded a comparatively higher 8.49% annualized return.
TEVA
- 1D
- -3.32%
- 1M
- -7.60%
- YTD
- 0.87%
- 6M
- 3.83%
- 1Y
- 84.53%
- 3Y*
- 61.02%
- 5Y*
- 25.48%
- 10Y*
- -4.49%
IHE
- 1D
- -1.02%
- 1M
- 4.07%
- YTD
- 8.99%
- 6M
- 9.73%
- 1Y
- 43.20%
- 3Y*
- 17.43%
- 5Y*
- 10.23%
- 10Y*
- 8.49%
TEVA vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.87% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
IHE iShares U.S. Pharmaceuticals ETF | 8.99% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between TEVA and IHE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since May 5, 2006 | 0.45 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. IHE — Risk / Return Rank
TEVA
IHE
TEVA vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TEVA | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.34 | ||
| Sortino ratioReturn per unit of downside risk | -0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.43 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 3.90 | 5.12 | -1.22 |
| Martin ratioReturn relative to average drawdown | 11.35 | 15.77 | -4.42 |
Loading charts...
Drawdowns
TEVA vs. IHE - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for TEVA and IHE.
Loading charts...
Drawdown Indicators
| TEVA | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -38.20% | -52.69% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -8.47% | -13.32% |
Max Drawdown (3Y)Largest decline over 3 years | -43.70% | -15.92% | -27.78% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -16.03% | -27.67% |
Max Drawdown (10Y)Largest decline over 10 years | -88.41% | -29.59% | -58.82% |
Current DrawdownCurrent decline from peak | -53.47% | -3.06% | -50.41% |
Average DrawdownAverage peak-to-trough decline | -32.01% | -7.90% | -24.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.47% | 2.75% | +4.72% |
Volatility
TEVA vs. IHE - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 10.98% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.20%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TEVA | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.98% | 5.20% | +5.78% |
Volatility (6M)Calculated over the trailing 6-month period | 24.19% | 12.58% | +11.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.87% | 17.19% | +21.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.85% | 16.27% | +26.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.37% | 18.06% | +29.31% |
Dividends
TEVA vs. IHE - Dividend Comparison
TEVA has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.60% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Frequently Asked Questions
TEVA and IHE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TEVA has higher volatility (10.98%) compared to IHE (5.20%). In terms of maximum drawdown, TEVA dropped -90.89% vs IHE's -38.20%.
IHE currently has the higher Sharpe Ratio (2.53 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TEVA and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer